Additional file 5 of BAFF is a marker of hypogammaglobulinemia, neuroaxonal damage and inflammation in multiple sclerosis patients on ocrelizumab

Figshare 2026 Dataset Open access

Read full text

Authors: Anastasia P. Chumakova, Lauren E. McKay, Victoria Fleming, Michael Demetriou, Michael Sy

DOI: 10.6084/m9.figshare.30994833.v1

Cited by: 0

Abstract

Supplementary Material 5: Supplementary Table 1. Analysis of best fit on the models used in the manuscript for data in each figure